← Eichor
Condition: Bile Duct Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Bile Duct Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic C
NA · 8 location(s) · Aichi Medical University · NCT07235007The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
Phase N/A · 1 location(s) · Samsung Medical Center · NCT03637569Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Phase 1/Phase 2 · 11 location(s) · Genfit · NCT05874414Intravital Microscopy in Human Solid Tumors
NA · 1 location(s) · Mayo Clinic · NCT03823144Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer
Phase 2 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT07025174PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
Phase 1 · 1 location(s) · Karolinska University Hospital · NCT05172310Efficacy of Fistulotomy for Biliary Cannulation
NA · 1 location(s) · Coordinación de Investigación en Salud, Mexico · NCT04037007Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study
NA · 1 location(s) · University Hospital Olomouc · NCT06964425Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas
Phase 3 · 1 location(s) · Minia University · NCT07155525Biobank for Cholestatic Liver Diseases.
Phase N/A · 1 location(s) · Mayo Clinic · NCT03445585Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study
Phase N/A · 32 location(s) · GERCOR - Multidisciplinary Oncology Cooperative Group · NCT04935853A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
Phase 1 · 2 location(s) · Chongqing Precision Biotech Co., Ltd · NCT06043466Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers
Phase 2 · 1 location(s) · National Cancer Center, Korea · NCT06135896Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01915225Prognostic Factors in Periampullary Tumors and Cysts
Phase N/A · 1 location(s) · Umeå University · NCT05155878PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Color
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05286814A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects W
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05849480Target-specific immunoPET Imaging of Digestive System Carcinoma
NA · 1 location(s) · RenJi Hospital · NCT06715839Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
Phase 4 · 20 location(s) · University of Leipzig · NCT05551299Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Chola
Phase 2 · 1 location(s) · Jinbo Yue · NCT07030140On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer
Phase N/A · 3 location(s) · Region Skane · NCT06877637Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer
Phase 2 · 4 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06274879LEOPARD Training and Validation Data Collection Study
Phase N/A · 22 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06675604Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside
Phase 2 · 1 location(s) · Erasmus Medical Center · NCT06888063EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
NA · 1 location(s) · Orlando Health, Inc. · NCT06340620Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
Phase N/A · 1 location(s) · Mayo Clinic · NCT04753996Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
NA · 1 location(s) · Cedars-Sinai Medical Center · NCT04907643Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699Registry for Advanced Endoscopy
Phase N/A · 1 location(s) · Region Stockholm · NCT05187312Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)
Phase N/A · 6 location(s) · Fujian Provincial Hospital · NCT06602011
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.